Report : Europe SPECT Equipment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Hybrid SPECT (SPECT-CT and SPECT-MR) and Standalone SPECT), Radioisotope Type (Iodine-123, Technetium-99m, Xenon-133, Thallium-201, Radium-223, Gallium-66, and Other Radioisotopes), Application (Seizures, Stroke, Stress Fractures, Infections, Tumors, and Others), and End User (Hospitals, Imaging Centers, and Others)
Technetium-99m Segment to Dominate Europe SPECT Equipment Market during 2021–2028
According to a new market research study on “Europe SPECT Equipment Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Type, Radioisotopes, Application, and End User” is expected to reach US$ 525.36 million by 2028 from US$ 398.87 million in 2021. The market is estimated to grow at a CAGR of 4.0% from 2021 to 2028. The report provides trends prevailing in the Europe SPECT equipment market along with the drivers and restraints pertaining to the market growth. Advancements in analysis of tumor imaging is the major factor driving the growth of the Europe SPECT equipment market. However, issues associated with the high price hinder the growth of Europe SPECT equipment market.
The Europe SPECT equipment market has been segmented based on type, radioisotopes, application, end user, and country. Based on type, the Europe SPECT equipment market is segmented into hybrid SPECT and standalone SPECT. The hybrid SPECT segment dominated the market in 2020 and is expected to be the fastest growing during the forecast period. Further, hybrid SPECT is bifurcated by SPECT-CT and SPECT-MR. Based on radioisotopes, the Europe SPECT equipment market is segmented into Iodine-123, Technetium-99m, Xenon-133, Thallium-201, Radium-223, Gallium-66, and other radioisotopes. The Technetium-99m segment dominated the market in 2020 and Ga-66 segment is expected to be the fastest growing during the forecast period. Based on application, the Europe SPECT equipment market is segmented into seizures, stroke, stress fractures, infections, tumors, and others. The stroke segment dominated the market in 2020 and tumors is expected to be the fastest growing during the forecast period. Based on end user, the Europe SPECT equipment market is segmented into hospitals, imaging centers, and others. The hospitals dominated the market in 2020 and imaging centers segment is expected to be the fastest growing during the forecast period. Based on country, the Europe SPECT equipment market is classified into Germany, France, Italy, UK, Spain, and Rest of Europe.
Countries in the European regions were greatly affected due to the COVID-19 pandemic, particularly diagnostic practice. According to the findings published on PubMed, the pandemic posed a significant challenge to NM departments, and every center in Europe witnessed a workforce loss. To prevent COVID-19 transmission, NM agencies implemented restrictions such as postponing non-high-priority procedures. Due to COVID-19, several departments encountered delays in receiving radiopharmaceuticals, which are used in SPECT equipment, as well as technical help. As a result, the pandemic reduced the number of diagnostic and therapeutic NM operations performed, as well as the degree of care provided to patients with diseases other than COVID-19, such as cancer or acute cardiovascular disease. According to the results of the British Nuclear Medicine Society (BNMS) COVID-19 survey, around 97% of NM departments introduced procedures to limit SARS-CoV-2 transmission; at 68% of sites, standardized operating procedures were developed for running departments in pandemic situations. As per the global survey by Freudenberg et al., around 15% of the respondent departments modified working hours for less than 20% of the staff and reported a mean decline of 54.4% in diagnostic procedures. Nuclear scans decreased by a mean of 36%; thyroid scans decreased by 67%; myocardial studies by 66%; bone scans by 60%; lung scans by 56%; and sentinel lymph node procedures by 45%. Nearly all (97%) participating centers in the survey from Germany, Austria, and Switzerland reported a decline in diagnostic NM procedures. In addition, nuclear cardiology was one of the most affected branches of NM during the COVID-19 pandemic in the region. All non-urgent examinations were postponed, and a decrease in 32% and 31% of activity was observed in NHS England PET/CT services in April and May 2020, respectively. Apart from this, new findings supporting COVID-19 diagnosis are expected to accelerate the growth of SPECT Equipment in the region. With the role of SPECT in the COVID-19, the research studies can also pave the way in combating other epidemics in the future.
Bracco Imaging S.p.A.; Bruker Corporation; Cardinal Health, Inc; Curium; Lantheus Medical Imaging Inc.; Mediso Ltd.; MiE GmbH; NTP RADIOISOTOPES; and Spectrum Dynamics Medical are among the leading companies in the Europe SPECT Equipment market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2021, Curium has announced to invest in new jobs at its Noblesville location to expand our footprint and capabilities at our Noblesville facility to provide our customers and patients reliable access to our innovative products.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com